What is GALNF stock price today?

GALNF (Galenica AG) stock is trading at $116.19 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is GALNF stock going up or down today?

GALNF stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy GALNF stock now?

The decision to buy GALNF depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is GALNF a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for GALNF based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is GALNF stock overvalued or undervalued?

GALNF currently trades at a P/E ratio of 24.83 relative to earnings. Our DCF calculator provides intrinsic value estimates to help determine if GALNF is fairly priced.

What is GALNF's P/E ratio?

GALNF has a price-to-earnings (P/E) ratio of 24.83, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.

What is GALNF's market cap?

GALNF (Galenica AG) has a market capitalization of $6.17 billion, making it a small-cap stock.

What is GALNF's price to book ratio?

GALNF trades at a price-to-book (P/B) ratio of 3.05, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does GALNF pay dividends?

Yes, GALNF pays dividends with a current yield of 0.02%. Dividend payments provide income for investors in addition to potential stock price appreciation.

What is GALNF's dividend yield?

GALNF's dividend yield is 0.02%, calculated as annual dividends divided by the current stock price. This represents the annual return from dividends alone.

Is GALNF stock a good long-term investment?

GALNF's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is GALNF's revenue growth rate?

GALNF has shown revenue growth of 0.1% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.

Yes, GALNF is profitable with a profit margin of 0.0%. This indicates the company generates 0.0 cents of profit for every dollar of revenue.

What are the risks of investing in GALNF?

Key risks for GALNF include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does GALNF compare to its competitors?

Compare GALNF to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize GALNF's performance and positioning.

What is GALNF's stock price target for 2026?

Our AI model provides price targets for GALNF based on fundamental analysis: Bull case $151.05 (+30%), Base case $133.62 (+15%), Bear case $104.57 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about GALNF?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for GALNF. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is GALNF's next earnings report?

GALNF reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

GALNF - Galenica AG

NYSE * Healthcare * Medical Distribution

$116.19

+$0.00 (+0.00%)

About Galenica AG

Galenica AG provides healthcare services in Switzerland and internationally. It operates through two segments, Products & Care, and Logistics & IT. The Products & Care segment operates and manages pharmacies and partner pharmacies under the Amavita, Sun Store, and Coop Vitality brands, as well as covers specialty pharmacy mediservice. This segment also offers medication for treatment of patients at home; laboratory medicine, pathology and specialized personalized diagnostic services; and develops, markets, and sells healthcare services and products through various distribution channels. The Logistics & IT segment provides various specialized pre-wholesale services, including storage, distribution, and debt collection to pharmaceutical and healthcare companies. This segment also offers master data systems for the healthcare market; develops management solutions for the healthcare market; and publishes printed and electronic technical information on pharmaceutical products, as well as offers complete management solutions for pharmacies. In addition, it provides on-schedule delivery services to pharmacies, drugstores, doctors, hospitals, and care homes. The company was founded in 1927 and is headquartered in Bern, Switzerland.

GALNF Key Statistics

Market Cap

$6.17B

P/E Ratio

24.83

P/B Ratio

3.05

EPS

$4.68

Dividend Yield

0.02%

Revenue Growth

+0.1%

Profit Margin

0.0%

Employees

4,727

How GALNF Compares to Peers

GALNF is the smallest among peers, which may offer higher growth potential

P/E Rank

of 6

Margin Rank

of 6

Growth Rank

of 6

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
GALNF(This stock)	$6.17B	24.8	0%	0.0%	-
UNHUnitedhealth Group	$287.19B	23.9	0%	0.0%	vs UNH
JNJJohnson &	$565.22B	21.3	0%	0.2%	vs JNJ
LLYEli Lilly	$809.09B	39.3	0%	0.3%	vs LLY
PFEPfizer Inc	$154.84B	20.0	-0%	0.1%	vs PFE
ABBVAbbvie Inc	$369.65B	88.6	0%	0.1%	vs ABBV

Galenica AG Company Information

Headquarters: Untermattweg 8, Bern, Switzerland, 3027, undefined
Website: www.galenica.com
Sector: Healthcare
Industry: Medical Distribution

About Galenica AG

GALNF Key Statistics

How GALNF Compares to Peers

Galenica AG Company Information

Upcoming Events for GALNF